Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial
NCT03005743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1050
Last updated 2026-02-23
Summary
Purpose of the study is to determine whether Image based brachytherapy is superior in terms of local control to Conventional radiograph based brachytherapy in locally advanced cervical cancers in a Phase III randomized setting.
Conditions
Interventions
- RADIATION
-
Magnetic Resonance Image based Brachytherapy
MRI based BT prescription will be in accordance to the GEC-ESTRO guidelines \[Intention will be to treat the whole cervix and the remaining residual tumour tissue at the primary site at the time of BT (high risk-clinical target volume) to a dose level analogue to the dose level previously prescribed for point-A\]
- RADIATION
-
Conventional Radiograph based Brachytherapy
The standard conventional radiography based prescription will be according to Manchester system Point A and bladder \& rectum ICRU point dose constraints
Sponsors & Collaborators
-
Tata Memorial Hospital
lead OTHER_GOV
Principal Investigators
-
Supriya Sastri (Chopra), MD · Professor, Department of Radiation Oncology, Tata memorial Hospital, Mumbai 400012
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2025-05-28
- Completion
- 2025-05-28
Countries
- India
Study Locations
More Related Trials
-
Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer
NCT04070976 ·Status: RECRUITING ·Phase: NA
-
Estimation of Tumor Response With Linac MRI-guided Adaptive Radiotherapy for Locally Advanced Cervical Cancer
NCT05942742 ·Status: UNKNOWN
-
Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix
NCT00193791 ·Status: COMPLETED ·Phase: NA
-
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
NCT06543576 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.
NCT06128460 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Reducing Radiation Target Volume for Stage IIb Cervical Cancer
NCT07249957 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
NCT06942416 ·Status: RECRUITING ·Phase: PHASE2
-
Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients
NCT05504642 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
NCT00104910 ·Status: COMPLETED ·Phase: PHASE1
-
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
NCT03955367 ·Status: UNKNOWN ·Phase: PHASE3
-
Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer
NCT06804135 ·Status: RECRUITING
-
Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer
NCT02835404 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer
NCT05735145 ·Status: RECRUITING ·Phase: PHASE3
-
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
NCT01554397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
NCT05570422 ·Status: RECRUITING ·Phase: PHASE1
-
Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer
NCT02247232 ·Status: COMPLETED ·Phase: PHASE3
-
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
NCT07232654 ·Status: RECRUITING ·Phase: PHASE2
-
Non-Invasive Cervical Cancer Radiotherapy for Stage IB-IVB
NCT03146039 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
NCT05492123 ·Status: RECRUITING ·Phase: PHASE2
-
Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer
NCT01295502 ·Status: UNKNOWN ·Phase: PHASE1
-
Advanced Cervical Cancer Trial in India
NCT01276730 ·Status: COMPLETED ·Phase: PHASE2
-
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
NCT03614949 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
NCT06288373 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Study on Early Stage Bulky Cervical Cancers
NCT01917695 ·Status: UNKNOWN ·Phase: PHASE3
-
QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced Cervical Cancer
NCT07205497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2